Velesco Pharma Acquires New R&D and cGMP Analytical Lab
Pharmaceutical Technology's In the Lab eNewsletter
he acquisition expands the company’s formulation and analytical R&D services.
Velesco Pharm, a development and clinical manufacturing company, has acquired a new facility in Wixom, MI, that expands and enhances its formulation and analytical R&D capabilities, the company announced on Oct. 23, 2018.
The acquisition and fit-out of the new facility double the company’s formulation and analytical laboratory space. The increase in capacity expands its research and cGMP services, including formulation development, analytical method development/validation, release and stability testing, and cGMP clinical manufacturing. The move to the expanded facility will occur before the end of 2018.
“Our new laboratory is impressively designed and equipped, and we will be increasing our scientific team such that we can meet our clients’ growing demand for pharmaceutical formulation and analytical services,” said Dave Barnes, PhD, CEO at Velesco, in a company press release.
Source: Velesco Pharm
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
